Literature DB >> 26335988

Design of a New Fluorescent Oligonucleotide-Based Assay for a Highly Specific Real-Time Detection of Apurinic/Apyrimidinic Site Cleavage by Tyrosyl-DNA Phosphodiesterase 1.

Natalia A Lebedeva1,2, Rashid O Anarbaev1,2, Maxim S Kupryushkin1, Nadejda I Rechkunova1,2, Dmitrii V Pyshnyi1,2, Dmitry A Stetsenko1, Olga I Lavrik1,2.   

Abstract

Tyrosyl-DNA phosphodiesterase 1 (Tdp1) promotes catalytic scission of a phosphodiester bond between the 3'-end of DNA and the hydroxyl group of a tyrosine residue, as well as cleaving off a variety of other 3'-terminal phosphate-linked DNA substituents. We have shown recently that Tdp1 can initiate an apurinic/apyrimidinic (AP) site repair pathway that is independent from the one mediated by AP endonuclease 1 (APE1). Until recently, there was no method available of tracking the AP-site cleaving activity of Tdp1 by real-time fluorescence assay. In the present study we demonstrate a highly specific real-time detection of the AP-site cleaving activity of Tdp1 which allows one to distinguish it from the activity of APE1 by using a short hairpin oligonucleotide with a 1,12-dodecanediol loop, a 5'-fluorophore, and a 3'-quencher. Specific phosphodiesterase activity of Tdp1, which is usually able to remove quencher from the 3'-end of DNA, was suppressed in our approach by introducing a noncleavable phosphate group mimic between the 3'-end and the quencher. As a nondigestible 3'-phosphate analogue, we have used a new uncharged tetramethyl phosphoryl guanidine (Tmg) group, which is resistant to 3'-phosphodiesterase cleavage.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26335988     DOI: 10.1021/acs.bioconjchem.5b00451

Source DB:  PubMed          Journal:  Bioconjug Chem        ISSN: 1043-1802            Impact factor:   4.774


  3 in total

Review 1.  Fluorescent Probes of DNA Repair.

Authors:  David L Wilson; Eric T Kool
Journal:  ACS Chem Biol       Date:  2017-11-30       Impact factor: 5.100

2.  Dysregulated human Tyrosyl-DNA phosphodiesterase I acts as cellular toxin.

Authors:  Selma M Cuya; Evan Q Comeaux; Keith Wanzeck; Karina J Yoon; Robert C A M van Waardenburg
Journal:  Oncotarget       Date:  2016-12-27

3.  Novel group of tyrosyl-DNA-phosphodiesterase 1 inhibitors based on disaccharide nucleosides as drug prototypes for anti-cancer therapy.

Authors:  Anastasia O Komarova; Mikhail S Drenichev; Nadezhda S Dyrkheeva; Irina V Kulikova; Vladimir E Oslovsky; Olga D Zakharova; Alexandra L Zakharenko; Sergey N Mikhailov; Olga I Lavrik
Journal:  J Enzyme Inhib Med Chem       Date:  2018-12       Impact factor: 5.051

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.